Please assess the completion status of the following clinical trial:

Trial Title: Effect of Timing Progesterone Luteal Support on Embryo Transfer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* first ICSI trial, normal uterus, normal cervix, normal ovarian response ,easy mock transfer,patient consenting~Exclusion Criteria:~* age over 38, difficult mock transfer, low and high ovarian response, patient not consenting

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 38 Years
- Healthy Volunteers: f

Study Arms:
- Egg retrieval arm (Type: EXPERIMENTAL): 67 ICSI cases are started daily 100 mg IM prontogest on the day of egg retrieval until the day of pregnancy test.
- Embryo transfer arm (Type: ACTIVE_COMPARATOR): 66 ICSI cases are started daily 100 mg IM prontogest on the day of embryo transfer until the day of pregnancy test.

Based on this trial design, predict the completion outcome and termination type (if applicable).